GRACE :: Lung Cancer
Denise Brock

Lung Cancer Video Library – Spanish Language: Video #41 Molecular Marker Testing for Advanced NSCLC

Share
download as a pdf file Download PDF of this page
 
GRACE Cancer Video Library - Lung

 

We are pleased to continue this series of informational videos for our Spanish speaking community.  GRACE is pleased to welcome Dr. Rafael Santana-Davila, Assistant Professor with the University of Washington School of Medicine and Seattle Cancer Care Alliance.  In this 41st video for the Spanish lung cancer video library, Dr. Santana-Davila joined GRACE to discuss molecular marker testing for advanced NSCLC.


 

 

 

How Did You Like This Video?

Please feel free to offer comments and raise questions in our Discussion Forums.


 

TRANSCRIPTS – Spanish and English
download transcripts
 

Marcador Molecular para Estadio Avanzado de Cancer de Células no Pequeñas

Molecular Marker Testing for Advanced NSCLC

 

Rafael Santana-Davila, MD
Assistant Professor of Medicine
University of Washington Seattle Cancer Care Alliance
Seattle, Washington

 

Spanish TRANSCRIPT

Cuando tratamos a un paciente en estadio tres lo que esperamos es curar al paciente, desafortunadamente esto solo se lleva en el 20 al 25% de los casos y en la mayoría de los pacientes el cancer aparece de regreso. Algo que hacemos comúnmente es la terapia de consolidación, que es dar más quimioterapia después de la quimioterapia y radiación. Para escoger si se da terapia de consolidación o no es según el régimen se haya escogido. Si el régimen incluyo carboplatino y paclitaxel se le da dos ciclos más de quimioterapia después de la radiación. Cuando la quimioterapia no incluye éste último, la ventaja de dar más ciclos de quimioterapia es controversial y se debe de discutir entre el paciente y el doctor.


  

English TRANSCRIPT

When we treat a patient in stage three we hope to cure the patient, but that only happens in about 20 to 25% of them and in most cases cancer comes back. Something we commonly use is consolidation therapy in which we give more chemotherapy after the one used in the chemotherapy and radiation therapy. Choosing if consolidation therapy is the best option is based on the regimen used. If the regimen included carboplatin and paclitaxel, we will give two more chemotherapy cycles after the radiation is over. When the chemotherapy did not include paclitaxel, the benefits of giving more chemotherapy are controversial and you have to discuss it with your doctor.


Comments are closed.

Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share
download as a pdf file Download PDF of this page

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share
download as a pdf file Download PDF of this page

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share
download as a pdf file Download PDF of this page

Subscribe to the GRACEcast Podcast on iTunes

Share
download as a pdf file Download PDF of this page

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share
download as a pdf file Download PDF of this page

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243